Antifibrotic compounds from Liriodendron tulipifera attenuating HSC-T6 proliferation and TNF-α production in RAW264.7

Eun Ju Jeong1, Na-Hyun Kim, Jeong-Doo Heo

  • 1Department of Agronomy & Medicinal Plant Resources, College of Life Sciences and Natural Resources, Gyeongnam National University of Science and Technology.

Insights

Liriodendron tulipifera extract inhibits liver fibrosis by reducing hepatic stellate cell proliferation. Key compounds like (-)-syringaresinol, (+)-dihydrodehydrodiconiferyl alcohol, and salvinal show potent antifibrotic effects without harming liver cells.

Area of Science:

  • Pharmacology
  • Natural Products Chemistry
  • Hepatology

Background:

  • Liver fibrosis is a significant health concern, with hepatic stellate cell (HSC) proliferation being a key therapeutic target.
  • Natural products offer potential avenues for developing novel antifibrotic agents.

Purpose of the Study:

  • To investigate the antifibrotic potential of Liriodendron tulipifera extract and identify active compounds.
  • To evaluate the efficacy and safety of isolated compounds in inhibiting HSC proliferation and related fibrotic processes.

Main Methods:

  • Bioactivity-guided isolation of compounds from L. tulipifera methanolic extract.
  • In vitro assays to assess inhibition of HSC proliferation (HSC-T6 cells).
  • Cytotoxicity testing on primary rat hepatocytes and assessment of collagen deposition and TNF-α production.

Main Results:

  • The L. tulipifera extract demonstrated significant inhibition of HSC proliferation.
  • Twelve compounds were isolated, with (-)-syringaresinol (2), (+)-dihydrodehydrodiconiferyl alcohol (3), and salvinal (4) showing potent antifibrotic activity.
  • Compounds 2, 3, and 4 reduced collagen deposition in HSCs and suppressed TNF-α production in macrophages without significant cytotoxicity to hepatocytes.

Conclusions:

  • (-)-Syringaresinol, (+)-dihydrodehydrodiconiferyl alcohol, and salvinal possess selective antifibrotic properties against activated HSCs.
  • These compounds also modulate pro-inflammatory responses, suggesting their potential as therapeutic candidates for liver fibrosis treatment.